Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Goldman Sachs Downgrades Align Tech to Sell, Lowers Price Target to $250

Goldman Sachs Downgrades Align Tech to Sell, Lowers Price Target to $250

Goldman Sachs analyst Nathan Rice downgrades Align Tech (NASDAQ:ALGN) from Buy to Sell and lowers the price target from $380 to $250.

byBenzinga Newsdesk

July 28, 2022

1 minute read

Goldman Sachs analyst Nathan Rice downgrades Align Tech (NASDAQ:ALGN) from Buy to Sell and lowers the price target from $380 to $250.

News

PeloBuddy Reports Peleton Services Down for Some Users

By Charles Gross

August 10, 10:24 AM

https://twitter.com/PeloBuddy/status/1557371522255396868

PTON

These 3 Energy Stocks Delivering High-Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts

By Avi Kapoor

February 12, 9:36 AM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

CHRD

UBS Maintains Neutral on LyondellBasell Industries, Raises Price Target to $91

By Benzinga Newsdesk

January 11, 9:58 AM

UBS analyst Joshua Spector maintains LyondellBasell Industries (NYSE:LYB) with a Neutral and raises the price target from $81 to $91.

LYB

Insiders Buying Rani Therapeutics And 1 Other Stock

By Lisa Levin

April 17, 7:30 AM

Although US stocks closed lower on Friday, there were a few notable insider trades.

FLCX

Goldman Sachs Downgrades Align Tech to Sell, Lowers Price Target to $250

Related Posts

PeloBuddy Reports Peleton Services Down for Some Users

These 3 Energy Stocks Delivering High-Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts

UBS Maintains Neutral on LyondellBasell Industries, Raises Price Target to $91

Insiders Buying Rani Therapeutics And 1 Other Stock